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Objectives: The Mikania laevigata extract (MLe) (popularly known in Brazil as “guaco”) possesses anti-inflammatory properties. In the present study we tested the effects of 
MLe in a periodontitis experimental model in rats. We also investigated possible mechanisms 
underlying such effects. Material and Methods: Periodontal disease was induced by a ligature 
placed around the mandibular first molars of each animal. Male Wistar rats were divided 
into 4 groups: non-ligated animals treated with vehicle; non-ligated animals treated with 
MLe (10 mg/kg, daily); ligature-induced animals treated with vehicle and ligature-induced 
animals treated with MLe (10 mg/kg, daily). Thirty days after the induction of periodontal 
disease, the animals were euthanized and mandibles and gingival tissues removed for 
further analysis. Results: Morphometric analysis of alveolar bone loss demonstrated that 
MLe-treated animals presented a decreased alveolar bone loss and a lower expression of 
the activator of nuclear factor-κB ligand (RANKL) measured by immunohistochemistry. 
Moreover, gingival tissues from the MLe-treated group showed decreased neutrophil 
migration myeloperoxidase (MPO) assay. Conclusions: These results indicate that MLe may 
be useful to control bone resorption during progression of experimental periodontitis in rats.
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INTRODUCTION
The periodontium is a topographically complex 
organ consisting of epithelial tissue and soft and 
mineralized connective tissue. The structures 
comprising the periodontium include gingiva, 
cementum, bone and periodontal ligament4. Several 
diseases affect the composition and integrity of 
periodontal structures causing the destruction of 
the connective tissue matrix and cells, the loss of 
fibrous attachment and the resorption of alveolar 
bone following an intense inflammatory response to 
bacteria7. Such diseases are highly prevalent among 
different world populations, being an important 
impact factor in health oral programs1. The main 
bacterial pathogens of periodontal diseases are 
gram-negative anaerobic species that express a 
number of potential virulence factors that stimulate 
an unbalanced production of several molecules 
and pro-inflammatory factors, being an important 
determinant in the disease outcome20.
Innumerous studies have shown that, although 
largely nonspecific, basic treatment consisting 
of oral hygiene instruction and subgingival 
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instrumentation is able to keep the microbial load at 
low levels10 and, if followed by daily self-performed 
oral hygiene and regular professional periodontal 
maintenance care, leads to periodontal health in 
most cases 3. However, due to its unique patient 
and site-specific characteristics, a small proportion 
of the population suffers from ‘‘refractory’’ types 
of periodontitis, showing inadequate resolution 
of inflammation and failure to return tissue to 
homeostasis25. Since knowledge of the pathways 
and processes underlying resolution of periodontal 
tissue inflammation have grown significantly, an 
increased interest in substances and/or drugs 
that may contribute to the restoration of tissue 
homeostasis has occurred as a more sophisticated 
biological treatment modality for recurrent types of 
periodontal disease16.
Several biological systems are candidates 
to modulate the inflammatory process involved 
in periodontal disease. evidence from animal 
experiments and short-term clinical trials 
demonstrate that anti-inflammatory drugs are able 
to decrease the rate of periodontal bone destruction 
by local inhibition of pro-inflammatory molecules24. 
In Brazil, the leaves of species of Mikania laevigata 
Schultz Bip. ex Baker, popularly known as “guaco”, 
have been widely used as infusions or plasters, 
while the crude extract of this species is commonly 
commercialized as phytomedicine. Guaco is 
also popular in Brazil as an anti-inflammatory, 
antispasmodic and pain-reliever for rheumatism, 
arthritis, intestinal inflammation and ulcers. Among 
the few pharmacological and phytochemical studies 
published, preparations obtained from aerial parts 
of Mikania laevigata have been described as anti-
ulcerogenic5, antimicrobial29, bronchodilatory26 and 
anti-inflammatory27, possibly accounted for by the 
presence of several chemical constituents.
Our research group has recently assessed the 
pharmacological properties and the underlying 
molecular mechanisms of Mikania laevigata, 
demonstrating that, in animals, its hydroalcoholic 
extract was able to reduce neutrophil migration and 
vascular permeability, and prevent the release of 
TNF-α and IL-1b2. Since such findings could promote 
a protective effect in periodontal tissues against 
damage, the aim of this study was to evaluate the 
immunomodulatory action of systemic injection 
of a “guaco” extract in a model of experimental 
periodontitis in rats.
MATERIAL AND METhODS
Source of Mikania laevigata and preparation 
of the “guaco” extract
The extract used in this study was previously 
obtained and tested as described elsewhere2. Briefly, 
the leaves of Mikania laevigata were collected at the 
Farm School of the University of Uberaba (Triângulo 
Mineiro, MG, Brazil). A voucher specimen (HUFU 
54.748) has been deposited at the Herbarium of 
the Federal University of Uberlândia, Brazil. The 
samples were collected before 10:00a.m., between 
days 15 and 17 of November and allowed to dry 
at 30°C in an oven with air renovation for 15 
days. The dry plant, triturated by knife mill, was 
extracted by maceration with 70% ethanol:water 
under continuous agitation (shaker) for three times 
during 7 days each totalizing 21 days [the end 
ratio between plant and solvent was 1:8 (w/v)], 
obtaining a crude extract. The crude extract was 
dried and filtered using filter paper, concentrated in 
air-forced chamber at 30°C until dry crude extract 
was obtained . Pharmacologic assays were carried 
out using dry crude extract dissolved in saline 
solution.
Animals
Forty male Wistar rats (250-350 g) were used in 
the study. The animals were kept in plastic cages 
with access to food and water ad libitum. Prior to 
the surgical procedures, all animals were allowed 
to acclimatize to the laboratory environment for a 
period of 5 days. All experiments were conducted 
in accordance with national health guidelines for 
the welfare of experimental animals and were 
approved by the ethics Committee of the University 
of Uberaba (protocol #001/2008).
Experimental animal design
experimental periodontitis was induced by 
a ligature placement. More specifically, under 
general anesthesia obtained by intramuscular 
administration of ketamine (1.0 mL/kg), ligature 
was placed and immobilized around both mandible 
first molars of each animal. The ligature was left 
in position for the whole experimental period so 
that inflammation could be constantly induced by 
the colonization of bacteria inside of it. One day 
following ligature placement, the animals were 
randomly assigned to one of the following groups 
(n=10): 1) animals without ligature placement 
receiving administration of empty vehicle (control); 
2) animals without ligature placement receiving 
administration of MLe; 3) animals with ligature 
receiving administration of saline; 4) animals with 
ligature receiving administration of subcutaneous 
MLe (10 mg/kg/day; 200 µL. MLe or vehicle was 
administered daily for 30 days. Twenty-four hours 
after the last injection, the animals were sacrificed 
by anesthetic overdose. The current dose was 
chosen based on a previous study showing that it 
was effective to diminish the carrageenan-induced 
peritonitis15.
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MPO activity assay
Neutrophil infiltration to the gingival tissues 
of rats was evaluated by MPO kinetic-colorimetric 
assay as previously described17. Samples of 
gingival tissue were collected in 50 mM K2HPO4 
buffer (pH 6.0) containing 0.5% hexadecyl 
trimethylammonium bromide (HTAB) and kept at 
-80°C until use. Samples were homogenized using 
a Polytron (PT3100) and centrifuged at 13,000 g for 
4 min. The resulting supernatant devoid of debris 
was subjected to MPO activity assay determined 
by spectrophotometer at 450 nm (Spectra max®; 
Molecular Devices Inc., Sunnyvale, CA, USA) with 
three readings within 1 min. Briefly, 10 μL of sample 
was mixed with 200 μL of 50 mM phosphate buffer 
pH 6.0, containing 0.167 mg/ml ο-dianisidine 
dihydrochloride and 0.0005% hydrogen peroxide. 
The MPO activity of samples was compared with 
a standard curve of neutrophils. The results were 
presented as MPO activity (number of neutrophils 
X mg gingival tissue).
histological and immunohistochemical 
analyses
The right and left jaws were dissected, 
fixed in 10% buffered neutral formalin for 48 
h and decalcified in a decalcifying solution of 
ethylenediaminetetraacetic acid (eDTA) 10% for 
3 months. After that, briefly washed in running 
tap water, dehydrated and embedded in paraffin 
wax. each sample was sliced into 6 mm sections 
in sagittal directions. Sections were mounted on 
glass slides and stained with hematoxylin and eosin 
(HE) for the evaluation of bone resorption. Using an 
image analysis system (Image J – National Institute 
of Health), the area of bone loss in the furcation 
region was histometrically determined as previously 
described17.
Additional sections were mounted on glass slides 
pre-treated with 3-aminopropyltriethoxy-silane 
(Sigma Chemical Co., St. Louis, MO, USA) and 
used for immunohistochemical analysis. Sections 
were treated with 3% hydrogen peroxide (H2O2) 
for 30 min to block endogenous peroxidase. To 
block the nonspecific binding of antibody, the 
sections were treated with phosphate buffered 
saline (PBS)-1% bovine serum albumin (Vector 
Laboratories, Burlingame, CA, USA) for 30 min 
at room temperature before incubation with the 
primary antibody (polyclonal antibodies against 
RANKL (1:50) (Santa Cruz Biotechnology, Santa 
Cruz, CA, USA) for 24 h at 4°C. Biotinylated 
secondary antibody was used (Sigma;1:100) for 60 
min at room temperature. The slides were treated 
with Vectastain ABC-AP kit (diluted at 1:100; Vector 
Laboratories) for 60 min at room temperature, and 
the specific reaction by each antibody was visualized 
using 3, 3’diaminobenzidine (DAB). The slides were 
then counterstained with Mayer’s hematoxylin, 
dehydrated through graded ethanol, cleared in 
xylene, and mounted in slides with the help of 
Permount mounting media (Fisher Scientific). 
Negative controls were obtained by omission of the 
primary antibodies.
At least 10 representative sections of 
each specimen were analyzed under a light 
microscope (Olympus BX50, Tokyo, Japan). 
Immunohistochemical analysis was performed 
individually by two previous calibrated examiners 
(JCC and VJS-F; Kappa index=0.97) that were blind 
Figure 1- Mikania laevigata extract (MLE) decreases 
alveolar bone resorption. Histology at the furcation of first 
molars sampled from the rats euthanized after 30 days 
of experiments is shown [hematoxylin and eosin(HE) 
staining]; (A) non-ligated animals treated with vehicle, (B) 
non-ligated animals treated with (MLE) (10 mg/kg/day for 
30 consecutive days), (C) ligature-induced periodontitis 
treated with vehicle for 30 days, (D) ligature-induced 
periodontitis treated with subcutaneous MLE (10 mg/kg/
day for 30 consecutive days). (E) Results are expressed 
as mean area (mm2) ± standard deviation of 10 animals 
in each group. Different symbols indicate intergroup 
statistical significance (ANOVA followed by Bonferroni’s 
test). Magnification at 40× objective (scale bar=100 μm)
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to the treatment conditions. The number of stained 
cells was counted and normalized in the area where 
bone resorption was taking place.
Statistical analysis
Data were expressed as mean±SD (standard 
deviation). Statistical comparisons between groups 
were made using ANOVA analysis of variance 
followed by Bonferroni test. Significance was 
accepted when the p value was ≤0.05.
RESULTS
Effect of MLE on furcation bone loss
To assess whether MLe would affect bone loss in 
the furcation region, HE sections were histometrically 
analyzed. The resorption area measured after the 
experimental period demonstrated that ligature 
induced experimental periodontitis significantly 
increased bone loss (p<0.05) (Figure 1C) when 
compared with both vehicle (0.31±0.03 mm2) and 
MLe (0.35±0.06 mm2) non-ligated groups, which 
were not different when compared with each other 
(p>0.05) (Figures 1A and 1B). Additionally, the 
results demonstrated that MLe administration 
(10 mg/kg, daily) was able to significantly inhibit 
(0.56±0.13 mm2; p<0.05) the volume of bone 
loss in ligated teeth (Figure 1D), however still 
higher when compared with the non-ligated teeth 
(p<0.05). The values of the resorption area of the 
three groups were represented in Figure 1.
Figure 3- Immunohistochemical staining for RANKL. 
Expression patterns of RANKL in the periodontal tissue 
at the furcation of first molars sampled from the rats 
euthanized at 30 days are shown. Low number of positive 
staining cells for RANKL was observed in the furcation of 
non-ligated animals treated with vehicle (A) as well the 
non-ligated animals treated with Mikania laevigata extract 
(MLE) (B). Increased number of RANKL positive cells 
were found in the furcation of the ligated-animals treated 
with vehicle (C). Lower number of RANKL stained cells 
were found in the furcation of the ligated-animals treated 
with MLE (10 mg/kg/day for 30 consecutive days). (E) 
Data are presented as median ± standard deviation of 
the average RANKL positive cells/per area of furcation. 
Negative control staining was carried out by the incubation 
with secondary antibody alone that showed lack of 
immunostaining pattern in all experimental groups (data 
not shown). # p<0.05 compared with control animals; * 
p<0.05 compared with ligature-induced periodontitis 
treated with vehicle (ANOVA followed by Bonferroni’s 
test). The figure is representative of at least 4 different 
sections obtained from each group. Scale bar at lower 
(40x) magnification=100 μm, and scale bar at higher 
(400x) magnification=20 μm
Figure 2- Mikania laevigata extract (MLE) decreases 
neutrophil migration to the gingival tissue. In order to 
estimate the relative numbers of infiltrating neutrophils 
in the gingival tissue, myeloperoxidase (MPO) activity 
present in the gingival tissue homogenates was 
measured. Results are shown as mean MPO activity 
± standard deviation. # p<0.05 compared with control 
animals; * p<0.05 compared with ligature-induced 
periodontitis treated with vehicle (ANOVA followed by 
Bonferroni’s test)
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Effect of MLE on neutrophil migration and 
RANKL expression
Next, the possible interference of MLe on 
neutrophil migration was investigated. According 
to MPO assay, MLe administration did not exert any 
significant effect on neutrophil accumulation on non-
ligated teeth (55.74±25.84 versus 53.14±15.21 
neutrophils x 106; p>0.05) by measuring gingival 
tissue MPO. On the other hand, the increased levels 
of neutrophil accumulation observed on ligated 
teeth (113.82±38.96 neutrophils x 106; p<0.05) 
were significantly decreased by MLE administration 
(61.23±10.12 neutrophils x 106; p<0.05) (Figure 
2). Thus, MLe was able to reduce neutrophil 
accumulation and consequently inflammation in 
the gingival tissue.
On the other hand, since a reduced bone 
resorption was observed in the MLe-treated group, 
we tested the hypothesis that MLe decreases 
the release of osteoclast regulatory factors. In 
this way, we used an immunohistochemistry 
assay to visualize the expression of RANKL 
on periodontal tissues. As shown in Figure 3, 
animals with ligated-induced periodontitis treated 
with MLe presented significantly less RANKL-
immunostained cells (76.25±64.40 immunostained 
cells; p<0.05) in the periodontal tissue when 
compared with ligated-animals treated with vehicle 
(242.00±46.23 immunostained cells). Non-ligated 
animals (49.66±18.23 immunostained cells) were 
not affected by MLe administration (45.75±22.42 
immunostained cells; p>0.05).
DISCUSSION
Oral diseases continue to be a major health 
problem worldwide. Tooth loss, caused by poor 
periodontal health (which affects up to 20% of the 
adult population worldwide) can lead to significant 
morbidity and premature death22. The economic 
impact of oral diseases is an important consideration 
with up to 10% of public health expenditure in 
developed countries related to curative dental care24. 
In cases where traditional and basic treatments are 
not able to arrest periodontal disease progression, 
the adjunct use of alternative substances aimed at 
modulating the host immune response is desirable. 
However, despite several agents being commercially 
available, most of these chemicals may present 
undesirable side effects9 and limited scientific 
evidence so far. It is recognized that most of the 
new drugs discovered in the last few decades have 
originated from nature17. Chemical constituents 
obtained from medicinal plants and other natural 
products have been increasingly used to treat many 
inflammatory diseases. In the present study, it 
was demonstrated that an extract obtained from 
Mikania laevigata, a popular medicinal plant in 
South American countries, was able to decrease 
alveolar bone loss, which may be explained, at 
least in part, by the lower expression of RANKL 
and decreased neutrophil migration observed on 
MLe-treated animals.
A growing body of research suggests that 
chronic periodontal disease involves a failure 
of inflammation resolution pathways to restore 
tissue homeostasis. Therefore, strategies to slow 
or arrest periodontal disease progression by the 
modulation of the host immune response have 
been investigated26. Among the commercially 
available substances earliest evaluated so far to 
modify resolution pathways, are the nonsteroidal 
anti-inflammatory drugs (NSAIDs). These agents 
antagonize proinflammatory pathways and/or 
signaling, preventing the production arachidonic 
acid metabolites that are proinflammatory mediators 
implicated in a variety of bone resorptive and 
tissue degrading processes18. Although in vitro14 
and experimental studies12 have shown promising 
results, periodontal clinical trials have not reached 
consistent clinical benefits when combined with 
conventional therapy26 besides having undesirable 
side effects when used in a long-term basis. Hence, 
the search for alternative products continues and 
natural phytochemicals isolated from plants used 
in traditional medicine are considered as good 
alternatives to synthetic chemicals23.
More recently, the number of reports of the use 
of traditional plants and natural products for the 
treatment of periodontal disease has increased. In 
vitro studies evaluating the antimicrobial potential 
of substances isolated from popular plants have 
demonstrated significant antimicrobial properties 
against periodontal pathogens21. In addition, 
in vivo studies in animals using compounds of 
natural plants such as baicalin6 and cannabinoids17 
observed a protective role against periodontal tissue 
breakdown in ligature-induced periodontitis, which 
was partially explained by their inhibitory effects 
on prostaglandins (COX-2), interleukins (IL-1β and 
TNF-α), nitric oxide and the bone related molecules 
RANK and RANKL. Our results corroborate with such 
previous findings, with the administration of MLE 
significantly decreasing alveolar bone resorption 
and promoting an inhibition of neutrophils influx 
and RANKL production.
In the progression of inflammatory diseases, 
the interactions of recruited neutrophils in the site 
of inflammation stimulate the local production of 
several inflammatory mediators that may further 
amplify the inflammatory response and injure 
the surrounding tissues13. In fact, our group 
recently assessed the pharmacological properties 
and the underlying molecular mechanisms of 
the hydroalcoholic MLE to confirm the popular 
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wisdom as a putative anti-inflammatory drug2. We 
could observe that the anti-inflammatory effect 
of MLe was able to reduce neutrophil migration 
and vascular permeability in a peritonitis model. 
MLe additionally prevented the release of both 
TNF-α and IL-1β and contributed to a reduction in 
leukocyte adhesion and transmigration across the 
endothelium as observed by intravital microscopy. 
Taken together, the results suggest that use of the 
medicinal guaco extract may be able to suppress 
the development of inflammatory lesions, which 
are initiated by neutrophil recruitment including 
periodontal conditions.
The  d i scovery  o f  the  RANK–RANKL–
Osteoprotegerin (OPG) system has brought rapid 
progress in the understanding of the regulatory 
mechanisms of osteoclast differentiation and 
activation exerted by the immune system28. 
Recent studies suggest the involvement of RANKL 
and OPG in the pathogenesis of periodontitis28. 
Not only osteoblasts but also other resident 
cells, including cells of the periodontal ligament, 
participate in the regulation of RANKL and OPG in 
periodontal tissue16,19. The findings of the present 
study, demonstrated that the administration of 
MLe inhibited the expression of RANKL. To the 
best of our knowledge, no direct effect of MLe on 
the RANK/RANKL/OPG system has been addressed 
in the literature. However, several investigations 
have addressed the close relation between the 
production of inflammatory mediators and the 
modulation of RANKL/OPG balance. During the 
progression of periodontal disease, high levels of 
pro-inflammatory cytokines have been positively 
related to RANKL expression, suggesting that 
such inflammatory molecules play a major role 
in periodontal bone resorption11. Interestingly, a 
recent work demonstrated that lipopolysaccharide 
(LPS), a toll-like receptor 4 ligand, up-regulated 
the expression of membrane RANKL in human 
blood neutrophils. Besides, LPS-activated human 
and murine neutrophils, cocultured with human 
monocyte-derived osteoclasts and RAW 264.7 cells, 
respectively, stimulated bone resorption8. Therefore 
it is possible to suggest that the potent anti-
inflammatory properties of MLE may have caused 
the diminished production of RANKL observed in 
MLe-treated animals observed in the present study 
and indirectly participated in the decreased volume 
of bone loss during ligature-induced periodontal 
disease progression.
CONCLUSION
There is considerable evidence that plant 
extracts have the potential to be developed 
into agents that can be used as preventative or 
treatment therapies for oral diseases. The results 
of the present investigation indicate that “guaco” 
extract may be useful to control bone resorption 
during progression of experimental periodontitis 
in rats in animal studies. While our results are 
encouraging, further controlled trial studies will 
be important to establish whether guaco is able to 
offer clinical therapeutic benefits.
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